BRIEF-Pfizer says 2 additional late stage studies of cholesterol drug met goals
June 28, 2016 at 09:24 AM EDT
* Two additional Phase 3 lipid-lowering studies of bococizumab deliver positive topline results
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.